| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/1440-1681.12550 |
| P8608 | Fatcat ID | release_tmxaa4wz4vdotaulj7cn2sw47y |
| P698 | PubMed publication ID | 26804705 |
| P2093 | author name string | Liping Xie | |
| Xin Tang | |||
| Yong Ji | |||
| Yue Gu | |||
| Guoliang Meng | |||
| P2860 | cites work | Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril | Q28215905 |
| Endothelial nitric oxide synthase in vascular disease: from marvel to menace | Q28305279 | ||
| Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress | Q29615436 | ||
| Oxidative stress as a regulator of gene expression in the vasculature | Q33751805 | ||
| Aliskiren - an alternative to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in the therapy of arterial hypertension | Q34247173 | ||
| Inflammatory monocytes determine endothelial nitric-oxide synthase uncoupling and nitro-oxidative stress induced by angiotensin II | Q34283413 | ||
| Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone | Q34378188 | ||
| Aliskiren attenuates steatohepatitis and increases turnover of hepatic fat in mice fed with a methionine and choline deficient diet | Q35035662 | ||
| Endothelial function testing as a biomarker of vascular disease | Q35569232 | ||
| Nitric oxide, an iceberg in cardiovascular physiology: far beyond vessel tone control | Q35704375 | ||
| Effect of aliskiren on vascular remodelling in small retinal circulation | Q35785397 | ||
| Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease | Q35845567 | ||
| cGMP-AMP synthase paves the way to autoimmunity | Q36207307 | ||
| Hypertension pharmacogenomics: in search of personalized treatment approaches | Q36652960 | ||
| Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms | Q36726069 | ||
| Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats. | Q37648622 | ||
| Endothelial dysfunction in experimental models of arterial hypertension: cause or consequence? | Q37677152 | ||
| Direct renin inhibition: from pharmacological innovation to novel therapeutic opportunities | Q37939271 | ||
| Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets? | Q38122012 | ||
| Nitric oxide and reactive oxygen species in limb vascular function: what is the effect of physical activity? | Q38130310 | ||
| New paradigms in inflammatory signaling in vascular endothelial cells | Q38166953 | ||
| Vascular oxidative stress, nitric oxide and atherosclerosis | Q38253137 | ||
| Endothelium-derived Relaxing Factors of Small Resistance Arteries in Hypertension | Q38262506 | ||
| Renin inhibition and AT(1)R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling. | Q40262966 | ||
| A Novel Arginase Inhibitor Derived from Scutellavia indica Restored Endothelial Function in ApoE-Null Mice Fed a High-Cholesterol Diet. | Q41057570 | ||
| Folic Acid Promotes Recycling of Tetrahydrobiopterin and Protects Against Hypoxia-Induced Pulmonary Hypertension by Recoupling Endothelial Nitric Oxide Synthase | Q41866231 | ||
| The renin inhibitor aliskiren upregulates pro-angiogenic cells and reduces atherogenesis in mice | Q42881647 | ||
| Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats | Q42972308 | ||
| Aliskiren prevents cardiovascular complications and pancreatic injury in a mouse model of obesity and type 2 diabetes | Q43247372 | ||
| Protective effects of aliskiren on ischemia-reperfusion-induced renal injury in rats | Q43679068 | ||
| Blood pressure lowering in essential hypertension with an oral renin inhibitor, aliskiren | Q44642058 | ||
| PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats | Q45098411 | ||
| Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice. | Q45930091 | ||
| Comparative effects of Aliskiren and Telmisartan in high fructose diet-induced metabolic syndrome in rats. | Q46171351 | ||
| Renin inhibitor aliskiren improves impaired nitric oxide bioavailability and protects against atherosclerotic changes | Q46470676 | ||
| Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine | Q46662652 | ||
| Direct renin inhibition with aliskiren improves ischemia-induced neovascularization: blood pressure-independent effect | Q46681423 | ||
| AMPKalpha1 regulates the antioxidant status of vascular endothelial cells | Q47801068 | ||
| Long-term effect of molsidomine, a direct nitric oxide donor, as an add-on treatment, on endothelial dysfunction in patients with stable angina pectoris undergoing percutaneous coronary intervention: results of the MEDCOR trial. | Q53542153 | ||
| Combined Aliskiren and L-arginine treatment reverses renovascular hypertension in an animal model. | Q53594610 | ||
| Reversal of endothelial nitric oxide synthase uncoupling and up-regulation of endothelial nitric oxide synthase expression lowers blood pressure in hypertensive rats. | Q54084809 | ||
| Handle region peptide counteracts the beneficial effects of the Renin inhibitor aliskiren in spontaneously hypertensive rats. | Q54387733 | ||
| The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes | Q56985191 | ||
| P433 | issue | 4 | |
| P921 | main subject | aorta | Q101004 |
| endothelium | Q111140 | ||
| P304 | page(s) | 450-458 | |
| P577 | publication date | 2016-01-25 | |
| P1433 | published in | Clinical and Experimental Pharmacology and Physiology | Q5133807 |
| P1476 | title | Aliskiren improves endothelium-dependent relaxation of thoracic aorta by activating PI3K/Akt/eNOS signal pathway in SHR. | |
| P478 | volume | 43 |
| Q92240832 | A Systems Pharmacology-Based Study of the Molecular Mechanisms of San Cao Decoction for Treating Hypertension |
| Q47369456 | Aliskiren protects against myocardial ischaemia-reperfusion injury via an endothelial nitric oxide synthase dependent manner |
| Q52632661 | Combined Antihypertensive Effect of Paeoniflorin Enriched Extract and Metoprolol in Spontaneously Hypertensive Rats. |
| Q89619897 | Kang Le Xin Reduces Blood Pressure Through Inducing Endothelial-Dependent Vasodilation by Activating the AMPK-eNOS Pathway |
| Q93047857 | MicroRNA-668-3p Protects Against Oxygen-Glucose Deprivation in a Rat H9c2 Cardiomyocyte Model of Ischemia-Reperfusion Injury by Targeting the Stromal Cell-Derived Factor-1 (SDF-1)/CXCR4 Signaling Pathway |
| Q92210228 | Protective Effects of Nanoparticle-Loaded Aliskiren on Cardiovascular System in Spontaneously Hypertensive Rats |
| Q33677627 | Salvia fruticosa Induces Vasorelaxation In Rat Isolated Thoracic Aorta: Role of the PI3K/Akt/eNOS/NO/cGMP Signaling Pathway. |
| Q91123985 | Sildenafil reduces aortic endothelial dysfunction and structural damage in spontaneously hypertensive rats: Role of NO, NADPH and COX-1 pathways |
| Q39198264 | The potential of stimulating nitric oxide formation in the treatment of hypertension |
Search more.